Delivering support through every stage of the pharmaceutical lifecycle

As leaders in API development and manufacturing, we support our customers’ projects from discovery to full commercial manufacture, while providing them access to emerging technologies, new efficiencies, and complete continuity along the way. Our customers include global pharmaceutical corporations and innovative biotechs, both of which have unique challenges and priorities at each stage of the complex molecule lifecycle. As leaders in API development and manufacturing, we support our customers’ projects from discovery to full commercial manufacture, while providing them access to emerging technologies, new efficiencies, and complete continuity along the way. Our customers include global pharmaceutical corporations and innovative biotechs, both of which have unique challenges and priorities at each stage of the complex molecule lifecycle. ... Read more

Molecule lifecycle services at Sterling

With the rising complexity of APIs in the pipeline today, complete project continuity has become increasingly critical to proactively address challenges, enhance efficiency, minimise costs, streamline development and manufacturing, and accelerate time to market. As a result, pharmaceutical and biotechnology organisations require an outsourced partner with the capabilities to support their product throughout its entire lifecycle, from grams to tonnes.

As a full service PDMO, or partnership development and manufacturing organisation, we have extensive expertise supporting our customers’ molecules from the earliest phases of discovery through to full commercial manufacture. In our global delivery network, our customers will find the world-class facilities, specialised equipment, and highly skilled team members they need to address a wide range of project requirements at every stage—all while benefiting from our simple way of working, our commitment to integrity, and our true scientific collaboration. Read less

Here’s how we accelerate your product’s path to market by delivering unrivalled support at every stage of the pharmaceutical lifecycle.

A comprehensive approach to preclinical discovery and development is critical to position projects for long-term success. We pair process development services, including Proof of Concept, Quality by Design, and Design of Experiments, with CMC support, to support the IND process and establish an efficient, cost-effective, and scalable pathway to market. By proactively anticipating and addressing challenges early on, we help our customers mitigate added costs and delays in the long run. In addition, our significant technology transfer (TT) expertise enables us to streamline the transfer process and maximise critical continuity.

Technologies & Services

Knowledge Hub Articles

An overview of Sterling Pharma Solutions

Antibody drug conjugates (ADC): The magic bullets

API manufacturing – exploring continuous processing

Biocatalysis webinar

Biocatalysis whitepaper

Biocatalysis: Using enzymes as catalysts

Environmental sustainability in the pharmaceutical industry

Full-lifecycle sustainability

High Potency APIs are on the rise

Making sense of regulatory requirements

Making Sense of Hazard Evaluation

Making sense of the pharmaceutical supply chain

Material Science at Sterling

Meet our Solid State experts

OncoTEX and Sterling sign clinical manufacturing agreement for development of novel treatment against ovarian cancer

Outsourcing the development of controlled substance APIs

Passion: What makes a PDMO?

Positioning your HPAPI programme for success webinar

Preclinical: Molecule Lifecycle Brief

Science: What makes a PDMO?

Scientist Snapshot: Head of Technology and Innovation, Mark Muldowney

Scientist Snapshot: Senior Director of Chemistry Research and Development, Krishna Kumar Ramanathan

Service: What makes a PDMO?

Solid form: Why is it important to consider in API development?

Sterling partners with Newcastle University to offer PhD project

Sterling Pharma Solutions acquires ADC Bio

Sterling Pharma Solutions acquires Alcami Germantown facility in US

Sterling Pharma Solutions announces acquisition of CiVentiChem in the US

Sterling: A journey with Chromeleon CDS

What is a PDMO?

Your Chromatography Data System – are you in control?

Service. Passion. Science.